227
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Experiences from intrathecal baclofen treatment based on medical records and patient- and proxy-reported outcome: a multicentre study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1037-1043 | Received 29 Jun 2017, Accepted 15 Dec 2017, Published online: 08 Jan 2018
 

Abstract

Purpose: To investigate patient satisfaction with intrathecal baclofen treatment, complications from the treatment, and the impact of general expectations on treatment outcome in relation to satisfaction.

Methods: A multicentre study with cross-sectional design. Data were collected through questionnaires and patient records. Patients were recruited from six outpatient intrathecal baclofen clinics in Sweden. Eighty-three patients who had been treated with intrathecal baclofen for 1–4 years were included. For patients unable to communicate, data were collected through a proxy. The Patient Global Impression of Change was used to measure patients’ general satisfaction with change from intrathecal baclofen treatment. The Life Orientation Test – revised, was used to measure general expectations/optimism.

Results: General satisfaction with intrathecal baclofen treatment was high; 51/77 patients reported “much improved” or “very much improved.” There was no relationship between the two main outcomes (general satisfaction and general expectations/optimism) (rs = 0.12, p = 0.382). The two groups; those who could and those who could not communicate, did differ regarding personal characteristics and should be evaluated as such.

Conclusions: Most patients/proxies reported a high level of satisfaction with intrathecal baclofen treatment. The reported satisfaction with intrathecal baclofen treatment was not dependent on general expectations.

    Implications for Rehabilitation

  • Patients with intrathecal baclofen treatment report low levels of health and quality of life at the same time as they are highly satisfied with their treatment.

  • Intrathecal baclofen should be equally offered to both optimistic and less optimistic patients.

  • Patients who are able to/not able to communicate, differs in characteristics and should be informed and followed up in different ways in daily clinical practice.

Acknowledgements

We would like to thank everyone who has contributed to the implementation of the study at each unit: Tommy Bergenheim, Kristin Nyman, Emmanouil Papadopoulos, Hans Bennebrant, Erik Eklund, Ylva Karolin, Lars Hyllienmark, Johanna Lindberg, Rosanna Ignell Mode, Cecilia Markström, Nils Ståhl, and Birgitta Kahlmeter.

Disclosure statement

Stina Gunnarsson reports payment for lectures and speaking services from Medtronic, Per Ertzgaard reports payment for lectures, speaking services and consultancy from Medtronic, IBSEN, and Allergan. No conflict of interest was reported by the other authors

Additional information

Funding

Financial support for this study was received from the County Council of Östergötland, the Medical Research Council of Southeast Sweden, and the Swedish Association of Persons with Neurological Disabilities.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 374.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.